GB201721421D0 - Chimeric antigen receptor - Google Patents

Chimeric antigen receptor

Info

Publication number: GB201721421D0
Authority: GB; United Kingdom
Prior art keywords: antigen receptor; chimeric antigen; chimeric; receptor; antigen
Prior art date: 2017-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1721421.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

UCL Business Ltd

Original Assignee

UCL Business Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-12-20

Filing date

2017-12-20

Publication date

2018-01-31

2017-12-20 Application filed by UCL Business Ltd filed Critical UCL Business Ltd

2017-12-20 Priority to GBGB1721421.4A priority Critical patent/GB201721421D0/en

2018-01-31 Publication of GB201721421D0 publication Critical patent/GB201721421D0/en

2018-12-19 Priority to PCT/GB2018/053691 priority patent/WO2019122875A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

GBGB1721421.4A 2017-12-20 2017-12-20 Chimeric antigen receptor Ceased GB201721421D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1721421.4A GB201721421D0 (en)	2017-12-20	2017-12-20	Chimeric antigen receptor
PCT/GB2018/053691 WO2019122875A1 (en)	2017-12-20	2018-12-19	Chimeric antigen receptor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1721421.4A GB201721421D0 (en)	2017-12-20	2017-12-20	Chimeric antigen receptor

Publications (1)

Publication Number	Publication Date
GB201721421D0 true GB201721421D0 (en)	2018-01-31

Family

ID=61008668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1721421.4A Ceased GB201721421D0 (en)	2017-12-20	2017-12-20	Chimeric antigen receptor

Country Status (2)

Country	Link
GB (1)	GB201721421D0 (en)
WO (1)	WO2019122875A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2022001799A (en) *	2019-08-15	2022-03-11	Janssen Biotech Inc	MATERIALS AND METHODS FOR IMPROVED SINGLE-CHAIN VARIABLE FRAGMENTS.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2502934B1 (en) *	2011-03-24	2018-01-17	Universitätsmedizin der Johannes Gutenberg-Universität Mainz	Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
US20160280798A1 (en) *	2013-11-06	2016-09-29	The United States Of America, As Represented By The Secretary Department Of Health & Human Service	Alk antibodies, conjugates, and chimeric antigen receptors, and their use
GB201405845D0 (en) *	2014-04-01	2014-05-14	Ucl Business Plc	Signalling system
US20170049819A1 (en) *	2014-04-25	2017-02-23	Bluebird Bio, Inc.	Kappa/lambda chimeric antigen receptors

2017
- 2017-12-20 GB GBGB1721421.4A patent/GB201721421D0/en not_active Ceased
2018
- 2018-12-19 WO PCT/GB2018/053691 patent/WO2019122875A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2019122875A1 (en)	2019-06-27

Publication	Publication Date	Title
IL254254B (en)	2021-04-29	Chimeric antigen receptor
GB201503742D0 (en)	2015-04-22	Chimeric antigen receptor
GB201607968D0 (en)	2016-06-22	Chimeric antigen receptor
GB201610512D0 (en)	2016-08-03	Chimeric antigen receptor
SG11201606790XA (en)	2016-09-29	Chimeric antigen receptor
SG11202102781UA (en)	2021-04-29	Chimeric antigen receptor
PT3294764T (en)	2021-02-15	Chimeric antigen receptor compositions
IL250536A0 (en)	2017-03-30	Chimeric antigen receptors
GB201617290D0 (en)	2016-11-23	Novel chimeric antigen receptors
IL251030A0 (en)	2017-04-30	Chimeric antigen receptors
ZA201906321B (en)	2021-02-24	Chimeric antigen receptor
GB201709508D0 (en)	2017-08-02	Chimeric antigen receptor
GB201801831D0 (en)	2018-03-21	Chimeric receptor
GB201807862D0 (en)	2018-06-27	Chimeric antigen receptor
GB2585607B (en)	2022-09-07	Chimeric antigen receptor and application thereof
GB201519900D0 (en)	2015-12-23	Chimeric antigen receptor
GB201721421D0 (en)	2018-01-31	Chimeric antigen receptor
GB201810451D0 (en)	2018-08-08	Anti-placenta-chondroitin-sulfate chimeric antigen receptor and application thereof
GB201815775D0 (en)	2018-11-14	Chimeric antigen receptor
GB201809773D0 (en)	2018-08-01	Chimeric antigen receptor
GB201807866D0 (en)	2018-06-27	Chimeric antigen receptor
GB201612844D0 (en)	2016-09-07	Chimeric antigen receptor
GB201612533D0 (en)	2016-08-31	Chimeric antigen receptor
GB201604387D0 (en)	2016-04-27	Chimeric antigen receptor
HK40013263A (en)	2020-08-07	Chimeric antigen receptor

Legal Events

Date	Code	Title	Description
2019-09-11	AT	Applications terminated before publication under section 16(1)